retatrutide trial news today Retatrutide, an experimental weight-loss drug, has not been approved by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS investigation Retatrutide UK Guide: Key Facts
Description
The separate TRANSCEND-T2D Phase 3 program covers type 2 diabetes (TRANSCEND-T2D-1 reported topline results March 19, 2026)

Bian: These drugs are new, and theyre evolving

It binds to the glucagon-like peptide 1 (GLP-1) hormone and potentiates the synthesis and secretion of insulin from pancreatic -cells in a glucose-induced manner (Underwood et al., 2009)

Without testing, Marco, 53, told me, he would never have injected retatrutide from the internet